IBDEI3IP ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,1817,0)
;;=NEW PATIENT^2^165
;;^UTILITY(U,$J,358.4,1818,0)
;;=ESTABLISHED PATIENT^1^165
;;^UTILITY(U,$J,358.4,1819,0)
;;=CONSULTATIONS^3^165
;;^UTILITY(U,$J,358.4,1820,0)
;;=PREGNANCY COMPLICATIONS^9^166
;;^UTILITY(U,$J,358.4,1821,0)
;;=PREGNANCY-HYPERTENSION^12^166
;;^UTILITY(U,$J,358.4,1822,0)
;;=PREGNANCY-VOMITING^15^166
;;^UTILITY(U,$J,358.4,1823,0)
;;=LATE PREGNANCY^6^166
;;^UTILITY(U,$J,358.4,1824,0)
;;=PREGNANCY-OTH COMPLICATIONS^13^166
;;^UTILITY(U,$J,358.4,1825,0)
;;=PREGNANCY CONDITIONS^10^166
;;^UTILITY(U,$J,358.4,1826,0)
;;=MULTIPLE GESTATIONS^8^166
;;^UTILITY(U,$J,358.4,1827,0)
;;=PREGNANCY-FETAL ABNORMALITY^11^166
;;^UTILITY(U,$J,358.4,1828,0)
;;=AMNIO/MEMBRANE PROBLEMS^1^166
;;^UTILITY(U,$J,358.4,1829,0)
;;=MAJOR PUERPERAL INFECTIONS^7^166
;;^UTILITY(U,$J,358.4,1830,0)
;;=VENOUS COMPLICATIONS^18^166
;;^UTILITY(U,$J,358.4,1831,0)
;;=PREGNANCY-PYREXIA^14^166
;;^UTILITY(U,$J,358.4,1832,0)
;;=PUERPERIUM COMPLICATIONS^17^166
;;^UTILITY(U,$J,358.4,1833,0)
;;=INFECTIONS BREAST/NIPPLE^5^166
;;^UTILITY(U,$J,358.4,1834,0)
;;=PREGNANCY-Z CODES^16^166
;;^UTILITY(U,$J,358.4,1835,0)
;;=GYNECOLOGICAL/BREAST^4^166
;;^UTILITY(U,$J,358.4,1836,0)
;;=GENITOURINARY & RENAL^3^166
;;^UTILITY(U,$J,358.4,1837,0)
;;=GASTROINTESTINAL^2^166
;;^UTILITY(U,$J,358.4,1838,0)
;;=SPECIAL SERVICES^9^167
;;^UTILITY(U,$J,358.4,1839,0)
;;=CHEMO NURSE PROCEDURES^2^167
;;^UTILITY(U,$J,358.4,1840,0)
;;=INFUSION DRUGS^6^167
;;^UTILITY(U,$J,358.4,1841,0)
;;=BLOOD PRODUCTS^1^167
;;^UTILITY(U,$J,358.4,1842,0)
;;=DIAGNOSTIC PROCEDURES^3^167
;;^UTILITY(U,$J,358.4,1843,0)
;;=OTHER DRUGS^7^167
;;^UTILITY(U,$J,358.4,1844,0)
;;=IMMUNIZATION ADMINISTRATION^4^167
;;^UTILITY(U,$J,358.4,1845,0)
;;=IMMUNIZATIONS^5^167
;;^UTILITY(U,$J,358.4,1846,0)
;;=PROLONGED SERVICES^8^167
;;^UTILITY(U,$J,358.4,1847,0)
;;=NEW PATIENT^2^168
;;^UTILITY(U,$J,358.4,1848,0)
;;=ESTABLISHED PATIENT^1^168
;;^UTILITY(U,$J,358.4,1849,0)
;;=CONSULTATIONS^3^168
;;^UTILITY(U,$J,358.4,1850,0)
;;=ANEMIA^1^169
;;^UTILITY(U,$J,358.4,1851,0)
;;=ARTIFICIAL OPENING STATUS^2^169
;;^UTILITY(U,$J,358.4,1852,0)
;;=BREASTS and GYN NEOPLASMS^3^169
;;^UTILITY(U,$J,358.4,1853,0)
;;=COAGULATION DISORDERS^4^169
;;^UTILITY(U,$J,358.4,1854,0)
;;=COUNSELING AND SCREENING^5^169
;;^UTILITY(U,$J,358.4,1855,0)
;;=GENITOURINARY NEOPLASMS^6^169
;;^UTILITY(U,$J,358.4,1856,0)
;;=GI CANCER^7^169
;;^UTILITY(U,$J,358.4,1857,0)
;;=HEAD NECK AND LUNGS NEOPLASMS^8^169
;;^UTILITY(U,$J,358.4,1858,0)
;;=HEMOGLOBINOPATHIES^9^169
;;^UTILITY(U,$J,358.4,1859,0)
;;=LYMPHOID NEOPLASMS^10^169
;;^UTILITY(U,$J,358.4,1860,0)
;;=METASTATIC SITES^11^169
;;^UTILITY(U,$J,358.4,1861,0)
;;=MALIGNANT NEOPLASMS OF OTHER SITES^12^169
;;^UTILITY(U,$J,358.4,1862,0)
;;=MYELOID NEOPLASMS AND DISORDERS^13^169
;;^UTILITY(U,$J,358.4,1863,0)
;;=NEOPLASM OF UNCERTAIN BEHAVIOR^14^169
;;^UTILITY(U,$J,358.4,1864,0)
;;=NEOPLASM OF UNSPECIFIED NATURE^15^169
;;^UTILITY(U,$J,358.4,1865,0)
;;=PERSONAL HISTORY^16^169
;;^UTILITY(U,$J,358.4,1866,0)
;;=INJECTION/ASPIRATION^3^170
;;^UTILITY(U,$J,358.4,1867,0)
;;=FRACTURE DISLOCATION^2^170
;;^UTILITY(U,$J,358.4,1868,0)
;;=APPLICATION CASTS/STRAPPING^1^170
;;^UTILITY(U,$J,358.4,1869,0)
;;=OTHER/REMOVAL/REVISION^4^170
;;^UTILITY(U,$J,358.4,1870,0)
;;=SUPPLIES/SOFT GOODS^7^170
;;^UTILITY(U,$J,358.4,1871,0)
;;=SUPPLIES/DRUGS^6^170
;;^UTILITY(U,$J,358.4,1872,0)
;;=REPAIR/CLOSURE-SIMPLE^5^170
;;^UTILITY(U,$J,358.4,1873,0)
;;=NEW PATIENT^2^171
;;^UTILITY(U,$J,358.4,1874,0)
;;=ESTABLISHED PATIENT^1^171
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3IP 3971 printed Apr 09, 2024@21:25:15 Page 2
IBDEI3IP ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,1817,0)
+2 ;;=NEW PATIENT^2^165
+3 ;;^UTILITY(U,$J,358.4,1818,0)
+4 ;;=ESTABLISHED PATIENT^1^165
+5 ;;^UTILITY(U,$J,358.4,1819,0)
+6 ;;=CONSULTATIONS^3^165
+7 ;;^UTILITY(U,$J,358.4,1820,0)
+8 ;;=PREGNANCY COMPLICATIONS^9^166
+9 ;;^UTILITY(U,$J,358.4,1821,0)
+10 ;;=PREGNANCY-HYPERTENSION^12^166
+11 ;;^UTILITY(U,$J,358.4,1822,0)
+12 ;;=PREGNANCY-VOMITING^15^166
+13 ;;^UTILITY(U,$J,358.4,1823,0)
+14 ;;=LATE PREGNANCY^6^166
+15 ;;^UTILITY(U,$J,358.4,1824,0)
+16 ;;=PREGNANCY-OTH COMPLICATIONS^13^166
+17 ;;^UTILITY(U,$J,358.4,1825,0)
+18 ;;=PREGNANCY CONDITIONS^10^166
+19 ;;^UTILITY(U,$J,358.4,1826,0)
+20 ;;=MULTIPLE GESTATIONS^8^166
+21 ;;^UTILITY(U,$J,358.4,1827,0)
+22 ;;=PREGNANCY-FETAL ABNORMALITY^11^166
+23 ;;^UTILITY(U,$J,358.4,1828,0)
+24 ;;=AMNIO/MEMBRANE PROBLEMS^1^166
+25 ;;^UTILITY(U,$J,358.4,1829,0)
+26 ;;=MAJOR PUERPERAL INFECTIONS^7^166
+27 ;;^UTILITY(U,$J,358.4,1830,0)
+28 ;;=VENOUS COMPLICATIONS^18^166
+29 ;;^UTILITY(U,$J,358.4,1831,0)
+30 ;;=PREGNANCY-PYREXIA^14^166
+31 ;;^UTILITY(U,$J,358.4,1832,0)
+32 ;;=PUERPERIUM COMPLICATIONS^17^166
+33 ;;^UTILITY(U,$J,358.4,1833,0)
+34 ;;=INFECTIONS BREAST/NIPPLE^5^166
+35 ;;^UTILITY(U,$J,358.4,1834,0)
+36 ;;=PREGNANCY-Z CODES^16^166
+37 ;;^UTILITY(U,$J,358.4,1835,0)
+38 ;;=GYNECOLOGICAL/BREAST^4^166
+39 ;;^UTILITY(U,$J,358.4,1836,0)
+40 ;;=GENITOURINARY & RENAL^3^166
+41 ;;^UTILITY(U,$J,358.4,1837,0)
+42 ;;=GASTROINTESTINAL^2^166
+43 ;;^UTILITY(U,$J,358.4,1838,0)
+44 ;;=SPECIAL SERVICES^9^167
+45 ;;^UTILITY(U,$J,358.4,1839,0)
+46 ;;=CHEMO NURSE PROCEDURES^2^167
+47 ;;^UTILITY(U,$J,358.4,1840,0)
+48 ;;=INFUSION DRUGS^6^167
+49 ;;^UTILITY(U,$J,358.4,1841,0)
+50 ;;=BLOOD PRODUCTS^1^167
+51 ;;^UTILITY(U,$J,358.4,1842,0)
+52 ;;=DIAGNOSTIC PROCEDURES^3^167
+53 ;;^UTILITY(U,$J,358.4,1843,0)
+54 ;;=OTHER DRUGS^7^167
+55 ;;^UTILITY(U,$J,358.4,1844,0)
+56 ;;=IMMUNIZATION ADMINISTRATION^4^167
+57 ;;^UTILITY(U,$J,358.4,1845,0)
+58 ;;=IMMUNIZATIONS^5^167
+59 ;;^UTILITY(U,$J,358.4,1846,0)
+60 ;;=PROLONGED SERVICES^8^167
+61 ;;^UTILITY(U,$J,358.4,1847,0)
+62 ;;=NEW PATIENT^2^168
+63 ;;^UTILITY(U,$J,358.4,1848,0)
+64 ;;=ESTABLISHED PATIENT^1^168
+65 ;;^UTILITY(U,$J,358.4,1849,0)
+66 ;;=CONSULTATIONS^3^168
+67 ;;^UTILITY(U,$J,358.4,1850,0)
+68 ;;=ANEMIA^1^169
+69 ;;^UTILITY(U,$J,358.4,1851,0)
+70 ;;=ARTIFICIAL OPENING STATUS^2^169
+71 ;;^UTILITY(U,$J,358.4,1852,0)
+72 ;;=BREASTS and GYN NEOPLASMS^3^169
+73 ;;^UTILITY(U,$J,358.4,1853,0)
+74 ;;=COAGULATION DISORDERS^4^169
+75 ;;^UTILITY(U,$J,358.4,1854,0)
+76 ;;=COUNSELING AND SCREENING^5^169
+77 ;;^UTILITY(U,$J,358.4,1855,0)
+78 ;;=GENITOURINARY NEOPLASMS^6^169
+79 ;;^UTILITY(U,$J,358.4,1856,0)
+80 ;;=GI CANCER^7^169
+81 ;;^UTILITY(U,$J,358.4,1857,0)
+82 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^169
+83 ;;^UTILITY(U,$J,358.4,1858,0)
+84 ;;=HEMOGLOBINOPATHIES^9^169
+85 ;;^UTILITY(U,$J,358.4,1859,0)
+86 ;;=LYMPHOID NEOPLASMS^10^169
+87 ;;^UTILITY(U,$J,358.4,1860,0)
+88 ;;=METASTATIC SITES^11^169
+89 ;;^UTILITY(U,$J,358.4,1861,0)
+90 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^12^169
+91 ;;^UTILITY(U,$J,358.4,1862,0)
+92 ;;=MYELOID NEOPLASMS AND DISORDERS^13^169
+93 ;;^UTILITY(U,$J,358.4,1863,0)
+94 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^14^169
+95 ;;^UTILITY(U,$J,358.4,1864,0)
+96 ;;=NEOPLASM OF UNSPECIFIED NATURE^15^169
+97 ;;^UTILITY(U,$J,358.4,1865,0)
+98 ;;=PERSONAL HISTORY^16^169
+99 ;;^UTILITY(U,$J,358.4,1866,0)
+100 ;;=INJECTION/ASPIRATION^3^170
+101 ;;^UTILITY(U,$J,358.4,1867,0)
+102 ;;=FRACTURE DISLOCATION^2^170
+103 ;;^UTILITY(U,$J,358.4,1868,0)
+104 ;;=APPLICATION CASTS/STRAPPING^1^170
+105 ;;^UTILITY(U,$J,358.4,1869,0)
+106 ;;=OTHER/REMOVAL/REVISION^4^170
+107 ;;^UTILITY(U,$J,358.4,1870,0)
+108 ;;=SUPPLIES/SOFT GOODS^7^170
+109 ;;^UTILITY(U,$J,358.4,1871,0)
+110 ;;=SUPPLIES/DRUGS^6^170
+111 ;;^UTILITY(U,$J,358.4,1872,0)
+112 ;;=REPAIR/CLOSURE-SIMPLE^5^170
+113 ;;^UTILITY(U,$J,358.4,1873,0)
+114 ;;=NEW PATIENT^2^171
+115 ;;^UTILITY(U,$J,358.4,1874,0)
+116 ;;=ESTABLISHED PATIENT^1^171
